Day: July 4, 2024

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

Pilgrims Bid Farewell to Madinah by Buying Gifts and Souvenirs

Madinah: The pilgrims bid farewell to Madinah after being blessed with the opportunity to perform Hajj and visit the Prophet’s Mosque, where they prayed and visited many mosques and historical landmarks in Madinah.

Most of the pilgrims conclude their…